跳至主要内容
临床试验/ISRCTN33310512
ISRCTN33310512已完成未知

Efficacy and tolerability of a topical skin-lightening CPP on subjects presenting facial dyspigmentation compared with 4% hydroquinone

ISISPHARMA0 个研究点目标入组 43 人开始时间: 2019年1月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
43

研究概览

简要总结

2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31858658 (added 19/02/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Women or men
  • 2. Aged between 18 and 60 years
  • 3. Skin phototype IV-V
  • 4. Presenting facial dyspigmentation due to melasma as determined by Wood’s light examination

排除标准

  • 1. Pregnant or nursing women or women planning to get pregnant during the study
  • 2. Subjects with a cutaneous pathology on the study zone (eczema)
  • 3. Subjects having undergone surgery under general anaesthesia within the previous month
  • 4. Individuals who have been excessively exposed to sunlight or UV-rays within the previous month
  • 5. Subjects having used topical or systemic treatment during the previous weeks liable to interfere with the assessment of the cutaneous acceptability of the study product

研究者

发起方
ISISPHARMA

相似试验